Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
14.54
+0.18 (1.25%)
At close: Mar 28, 2025, 4:00 PM
14.53
-0.01 (-0.05%)
After-hours: Mar 28, 2025, 7:56 PM EDT

Cartesian Therapeutics Market Cap

Cartesian Therapeutics has a market cap or net worth of $376.69 million as of March 28, 2025. Its market cap has increased by 322.77% in one year.

Market Cap
376.69M
Enterprise Value
178.06M
1-Year Change
322.77%
Ranking
Category
Stock Price
$14.54

Market Cap Chart

Since June 22, 2016, Cartesian Therapeutics's market cap has increased from $236.80M to $376.69M, an increase of 59.07%. That is a compound annual growth rate of 5.44%.

History

DateMarket Cap% Change
Mar 28, 2025376.70M-17.25%
Dec 31, 2024455.20M325.42%
Dec 29, 2023107.00M-38.11%
Dec 30, 2022172.90M-54.54%
Dec 31, 2021380.30M16.19%
Dec 31, 2020327.30M185.35%
Dec 31, 2019114.70M92.13%
Dec 31, 201859.70M-72.75%
Dec 29, 2017219.10M-29.78%
Dec 30, 2016312.00M31.76%
View and export this data all the way back to 2016. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 738.61B
UnitedHealth Group 472.03B
Johnson & Johnson 394.52B
AbbVie 363.15B
Novo Nordisk 305.46B
AstraZeneca 229.16B
Abbott Laboratories 226.88B
Merck & Co. 225.40B
Market Cap Rankings